AQR Capital Management
PCVX icon

AQR Capital Management’s Vaxcyte PCVX Stock Holding History

AQR Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
34,563
+9,105
+36% +$495K ﹤0.01% 2618
2026
Q1 		$1.48M Buy
25,458
+10,696
+72% +$581K ﹤0.01% 2558
2025
Q4 		$681K Buy
+14,762
New +$660K ﹤0.01% 2761
2025
Q3 		– Sell
-6,381
Closed -$207K – 3553
2025
Q2 		$207K Sell
6,381
-191
-3% -$6.26K ﹤0.01% 3032
2025
Q1 		$248K Sell
6,572
-17,944
-73% -$1.43M ﹤0.01% 2775
2024
Q4 		$2.01M Buy
24,516
+13,403
+121% +$1.33M ﹤0.01% 1536
2024
Q3 		$1.27M Buy
11,113
+253
+2% +$22.8K ﹤0.01% 1737
2024
Q2 		$820K Buy
10,860
+328
+3% +$22.3K ﹤0.01% 1841
2024
Q1 		$719K Sell
10,532
-1,568
-13% -$109K ﹤0.01% 1819
2023
Q4 		$760K Sell
12,100
-400
-3% -$20.8K ﹤0.01% 1709
2023
Q3 		$637K Sell
12,500
-1,870
-13% -$92.3K ﹤0.01% 1765
2023
Q2 		$718K Buy
14,370
+1,627
+13% +$77.1K ﹤0.01% 1685
2023
Q1 		$478K Buy
12,743
+1,306
+11% +$55.4K ﹤0.01% 1796
2022
Q4 		$548K Buy
11,437
+2,111
+23% +$82.8K ﹤0.01% 1781
2022
Q3 		$224K Buy
+9,326
New +$236K ﹤0.01% 2020

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AQR Capital Management's PCVX Position: Q2 2026 in Review

AQR Capital Management increased its Vaxcyte (PCVX) stake by 36% in Q2 2026, buying an estimated $495K and bringing the position to 34,563 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

AQR Capital Management first reported a position in PCVX in Q3 2022 and has held it in 15 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • AQR Capital Management held 34,563 shares of Vaxcyte worth $2.01M as of Q2 2026.
  • AQR Capital Management bought 9,105 Vaxcyte shares in Q2 2026, an estimated $495K.
  • Vaxcyte made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2618 holding.
  • AQR Capital Management first reported a position in Vaxcyte in Q3 2022 and has held it in 15 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.